IDBI Healthcare Fund Direct Growth

Equity
Sectoral-Pharma
High Risk
13.65%
3Y annualised
+0.55% 1D
1M
6M
1Y
3Y
All
NAV: 28 Jul 2023
₹20.26
Rating
NA
Min. SIP amount
Not Supported
Fund size
₹90.98Cr

Return calculator

Monthly SIP
One-Time
₹5,000 per month
Over the past
Total investment of 0
Would have become (%)

Holdings (20)

NameSectorInstrumentAssets
HealthcareEquity16.03%
HealthcareEquity10.66%
HealthcareEquity8.90%
HealthcareEquity8.86%
HealthcareEquity8.64%
HealthcareEquity6.54%
HealthcareEquity5.48%
HealthcareEquity4.21%
HealthcareEquity4.08%
HealthcareEquity3.73%
HealthcareEquity3.44%
HealthcareEquity2.75%
HealthcareEquity2.62%
HealthcareEquity2.40%
ChemicalsEquity2.26%
HealthcareEquity1.82%
ChemicalsEquity1.70%
HealthcareEquity1.33%
HealthcareEquity1.21%
HealthcareEquity1.19%
See All

Minimum investment amounts

Min. for 1st investmentNot Supported
Min. for 2nd investment onwardsNot Supported
Min. for SIPNot Supported

Returns and rankings

Category: Equity Sectoral-Pharma
Annualised returns
Absolute returns
6M1Y3YAll
Fund returnsNA13.6%13.7%17.3%
Category averageNA-0.2%23.1%NA
Rank with in categoryNA79NA
Understand terms

Expense ratio, exit load and tax

Expense ratio: 1.22%

Inclusive of GST

Exit load

Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.

Stamp duty

0.005% (from July 1st, 2020)

Tax implication

Returns are taxed at 20%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 12.5% on returns of Rs 1.25 lakh+ in a financial year.

Understand terms
Check past data

Fund management

Karan Doshi
Jul 2023 - Present
View details

Fund house & investment objective

Fund house contact details

Address
4th Floor, IDBI Tower,WTC Complex, Cuffe Parade,Colaba, Mumbai 400005
Phone
NA
Launch Date
29 Mar 2010
E-mail
NA
IDBI Mutual Fund
Asset Management Company
Custodian
SBI SG Global Securities Services Pvt.Ltd.
Registrar & Transfer Agent
KFin Tech
Address
Karvy House, No. 46, 8-2-609/K, Avenue 4, Street No.1 Banjara Hills,

Pros and cons

Category: Equity Sectoral-Pharma

Pros

Lower expense ratio: 1.24%

Cons

Consistently lower annualised returns than category average for the past 1Y and 3Y

Compare funds

IDBI Healthcare Fund Direct Growth
VS
Add mutual fund to compare